在早产新生儿中对咖啡因的生理基础的药理动力学建模:功能和损伤对剂量的影响
Nolan Thomas1, Matthew W Harer2, Sin Yin Lim1
1Pharmacy Practice and Translational Research Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.
Journal of clinical pharmacology
|November 28, 2025
概括
新生儿的咖啡因酸盐剂量需要根据妊娠年龄和功能进行调整. 过早出生的婴儿可能需要更低的剂量,而患有功能障碍的婴儿则需要大幅减少剂量,以维持治疗性咖啡因水平.
科学领域:
- 新生儿药理学 新生儿药理学
- 药理动力学 药理动力学
- 计算建模 计算建模
背景情况:
- 目前基于体重的咖啡因酸盐剂量对所有新生儿都是统一的.
- 妊娠年龄和功能显著影响咖啡因的新陈代谢和排泄.
- 优化咖啡因剂量对于早产婴儿至关重要.
研究的目的:
- 改进一个基于生理学的药理动力学 (PBPK) 模型,用于早产新生儿的咖啡因.
- 为了评估最佳的咖啡因剂量策略,考虑到不同的妊娠年龄和功能.
- 在虚拟早产人群中模拟咖啡因血度-时间概况.
主要方法:
- 使用Simcyp软件对咖啡因现有的PBPK模型进行了改进.
- 整合现实世界的体重与年龄的增长数据,以创建虚拟的早产人口.
- 更新CYP1A2本体生成模型并调整干净度和分布参数的体积.
主要成果:
- 精细的PBPK模型准确地反映了观察到的药理动力学数据.
- 模拟表明,较低妊娠年龄 (≤28周) 的新生儿可能需要较低的维持剂量 (8毫克/公斤) 与高GA新生儿 (10毫克/公斤) 相比.
- 功能显著下降的新生儿可能需要剂量减少两到三倍.
结论:
- 个性化咖啡因酸盐剂量对于早产新生儿是必要的.
- 妊娠年龄和功能是最佳咖啡因剂量的关键决定因素.
- 需要进一步的研究,以确定新生儿咖啡因治疗的精确治疗点.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
176
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
176
Pharmacokinetics in Pediatric Patients: Drug Excretion
195
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
195
Pharmacokinetics in Pediatric Patients: Drug Distribution
244
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
244
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
231
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
231
Drug Dosing: Infants and Children
234
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
234
Pharmacokinetic Models: Comparison and Selection Criterion
309
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
309


